Home Stock

Stock Research: Pfizer Limited

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Pfizer Limited

BSE:500680 INE182A01018
100
  • Value
    42
  • Growth
    74
  • Safety
    Safety
    90
  • Combined
    90
  • Sentiment
    90
  • 360° View
    360° View
    100
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Pfizer Limited is an India-based multinational pharmaceutical company. It focuses on Vaccines (Prevenar 13), Hospitals (advanced anti-infectives), Internal Medicine (respiratory, gastrointestinal, pain, cardiovascular), and Inflammation and Immunology (chronic autoimmune diseases, with brands like Enbrel). In the last fiscal year, the company had a market cap of $2848 million, profits of $166 million, and revenue of $267 million, with 1598 employees.

more
Strongest Rank Price vs. Sales (P/S)
Weakest Rank 360° View
Country India
Industry Pharmaceuticals
Size Small
Website pfizerindia.com
Index
Pfizer Limited stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
42 55 39 33
Growth
74 15 37 25
Safety
Safety
90 76 72 65
Sentiment
90 43 57 14
360° View
360° View
100 44 59 11
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
97 87 95 87
Opinions Change
50 23 50 50
Pro Holdings
n/a 51 58 6
Market Pulse
49 12 3 11
Sentiment
90 43 57 14
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
42 55 39 33
Growth
74 15 37 25
Safety Safety
90 76 72 65
Combined
90 48 47 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
41 53 39 37
Price vs. Earnings (P/E)
13 19 14 16
Price vs. Book (P/B)
52 55 45 31
Dividend Yield
57 60 63 60
Value
42 55 39 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
40 39 42 16
Profit Growth
75 39 27 65
Capital Growth
48 7 96 42
Stock Returns
69 35 29 31
Growth
74 15 37 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
74 74 66 78
Refinancing
71 64 66 46
Liquidity
81 61 63 61
Safety Safety
90 76 72 65

Similar Stocks

Discover high‑ranked alternatives to Pfizer Limited and broaden your portfolio horizons.

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Fleury

BOVESPA:FLRY3
Country: Brazil
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Maruti Suzuki

NSEI:MARUTI
Country: India
Industry: Automobile Manufacturers
Size: Large
Full Stock Analysis

Bosch

BSE:500530
Country: India
Industry: Auto Parts & Equipment
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews